Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04644770
Brief Title: A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

First Submitted : November 20, 2020
First Submitted that Met QC Criteria : November 20, 2020
First Posted : November 25, 2020

Last Update Submitted that Met QC Criteria : March 25, 2021
Last Update Posted : March 29, 2021